Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2013-07-09 16:10:40 UTC |
---|
Update Date | 2021-09-14 14:58:51 UTC |
---|
HMDB ID | HMDB0060979 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | hydroxyrepaglinide |
---|
Description | hydroxyrepaglinide belongs to the class of organic compounds known as phenylpiperidines. Phenylpiperidines are compounds containing a phenylpiperidine skeleton, which consists of a piperidine bound to a phenyl group. hydroxyrepaglinide is a strong basic compound (based on its pKa). hydroxyrepaglinide is a metabolite of repaglinide. Repaglinide is for the treatment of type II diabetes. Repaglinide belongs to the meglitinide class of blood glucose-lowering drugs. It is supplied by Novo Nordisk. It is sold in Japan by Dainippon Sumitomo Pharma. |
---|
Structure | CCOC1=C(C=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)=C1)C(O)=O InChI=1S/C27H36N2O5/c1-4-34-25-15-19(11-12-22(25)27(32)33)16-26(31)28-23(14-18(2)3)21-9-5-6-10-24(21)29-13-7-8-20(30)17-29/h5-6,9-12,15,18,20,23,30H,4,7-8,13-14,16-17H2,1-3H3,(H,28,31)(H,32,33) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C27H36N2O5 |
---|
Average Molecular Weight | 468.5851 |
---|
Monoisotopic Molecular Weight | 468.262422272 |
---|
IUPAC Name | 2-ethoxy-4-[({1-[2-(3-hydroxypiperidin-1-yl)phenyl]-3-methylbutyl}-C-hydroxycarbonimidoyl)methyl]benzoic acid |
---|
Traditional Name | 2-ethoxy-4-[({1-[2-(3-hydroxypiperidin-1-yl)phenyl]-3-methylbutyl}-C-hydroxycarbonimidoyl)methyl]benzoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | CCOC1=C(C=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)=C1)C(O)=O |
---|
InChI Identifier | InChI=1S/C27H36N2O5/c1-4-34-25-15-19(11-12-22(25)27(32)33)16-26(31)28-23(14-18(2)3)21-9-5-6-10-24(21)29-13-7-8-20(30)17-29/h5-6,9-12,15,18,20,23,30H,4,7-8,13-14,16-17H2,1-3H3,(H,28,31)(H,32,33) |
---|
InChI Key | OBMAZJVHPAVADF-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as phenylpiperidines. Phenylpiperidines are compounds containing a phenylpiperidine skeleton, which consists of a piperidine bound to a phenyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Piperidines |
---|
Sub Class | Phenylpiperidines |
---|
Direct Parent | Phenylpiperidines |
---|
Alternative Parents | |
---|
Substituents | - Phenylpiperidine
- Phenylacetamide
- Benzoic acid or derivatives
- Benzoic acid
- Phenoxy compound
- Benzoyl
- Phenol ether
- Tertiary aliphatic/aromatic amine
- Dialkylarylamine
- Aniline or substituted anilines
- Alkyl aryl ether
- Benzenoid
- Monocyclic benzene moiety
- Amino acid
- Tertiary amine
- Amino acid or derivatives
- Secondary carboxylic acid amide
- Secondary alcohol
- 1,2-aminoalcohol
- Carboxamide group
- Azacycle
- Carboxylic acid derivative
- Carboxylic acid
- Ether
- Monocarboxylic acid or derivatives
- Carbonyl group
- Alcohol
- Organooxygen compound
- Organic nitrogen compound
- Organic oxygen compound
- Amine
- Organonitrogen compound
- Organopnictogen compound
- Hydrocarbon derivative
- Organic oxide
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
hydroxyrepaglinide,1TMS,isomer #1 | CCOC1=CC(CC(=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)O[Si](C)(C)C)=CC=C1C(=O)O | 3689.0 | Semi standard non polar | 33892256 | hydroxyrepaglinide,1TMS,isomer #2 | CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O[Si](C)(C)C)C2)=CC=C1C(=O)O | 3754.0 | Semi standard non polar | 33892256 | hydroxyrepaglinide,1TMS,isomer #3 | CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)=CC=C1C(=O)O[Si](C)(C)C | 3703.1 | Semi standard non polar | 33892256 | hydroxyrepaglinide,2TMS,isomer #1 | CCOC1=CC(CC(=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O[Si](C)(C)C)C2)O[Si](C)(C)C)=CC=C1C(=O)O | 3632.8 | Semi standard non polar | 33892256 | hydroxyrepaglinide,2TMS,isomer #2 | CCOC1=CC(CC(=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)O[Si](C)(C)C)=CC=C1C(=O)O[Si](C)(C)C | 3590.6 | Semi standard non polar | 33892256 | hydroxyrepaglinide,2TMS,isomer #3 | CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O[Si](C)(C)C)C2)=CC=C1C(=O)O[Si](C)(C)C | 3603.9 | Semi standard non polar | 33892256 | hydroxyrepaglinide,3TMS,isomer #1 | CCOC1=CC(CC(=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O[Si](C)(C)C)C2)O[Si](C)(C)C)=CC=C1C(=O)O[Si](C)(C)C | 3552.9 | Semi standard non polar | 33892256 | hydroxyrepaglinide,1TBDMS,isomer #1 | CCOC1=CC(CC(=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)O[Si](C)(C)C(C)(C)C)=CC=C1C(=O)O | 3899.8 | Semi standard non polar | 33892256 | hydroxyrepaglinide,1TBDMS,isomer #2 | CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O[Si](C)(C)C(C)(C)C)C2)=CC=C1C(=O)O | 3964.6 | Semi standard non polar | 33892256 | hydroxyrepaglinide,1TBDMS,isomer #3 | CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 3928.9 | Semi standard non polar | 33892256 | hydroxyrepaglinide,2TBDMS,isomer #1 | CCOC1=CC(CC(=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O[Si](C)(C)C(C)(C)C)C2)O[Si](C)(C)C(C)(C)C)=CC=C1C(=O)O | 3985.0 | Semi standard non polar | 33892256 | hydroxyrepaglinide,2TBDMS,isomer #2 | CCOC1=CC(CC(=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O)C2)O[Si](C)(C)C(C)(C)C)=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 3946.0 | Semi standard non polar | 33892256 | hydroxyrepaglinide,2TBDMS,isomer #3 | CCOC1=CC(CC(O)=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O[Si](C)(C)C(C)(C)C)C2)=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 3967.2 | Semi standard non polar | 33892256 | hydroxyrepaglinide,3TBDMS,isomer #1 | CCOC1=CC(CC(=NC(CC(C)C)C2=CC=CC=C2N2CCCC(O[Si](C)(C)C(C)(C)C)C2)O[Si](C)(C)C(C)(C)C)=CC=C1C(=O)O[Si](C)(C)C(C)(C)C | 4023.2 | Semi standard non polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - hydroxyrepaglinide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0f89-1525900000-1959b7f9262511e8be3a | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - hydroxyrepaglinide GC-MS (3 TMS) - 70eV, Positive | splash10-01ba-3013049000-b5200b7086d1fc31a755 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - hydroxyrepaglinide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 10V, Positive-QTOF | splash10-0udi-0030900000-fe2a7576ecaa84ae291b | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 20V, Positive-QTOF | splash10-0nou-1290600000-eb578b1b9e8884297ce0 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 40V, Positive-QTOF | splash10-0cgl-4981200000-e78cbfb5dbcba53c745e | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 10V, Negative-QTOF | splash10-01b9-0000900000-24c355e900f6b491ceb6 | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 20V, Negative-QTOF | splash10-0ab9-0221900000-0fdb801af62fcc8ddb6c | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 40V, Negative-QTOF | splash10-0006-9757200000-91e7395dc03c6ce9feab | 2017-10-06 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 10V, Negative-QTOF | splash10-01b9-0321900000-49491f35a3279e76ffa3 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 20V, Negative-QTOF | splash10-0006-0429600000-ee2efac7b75996887bdf | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 40V, Negative-QTOF | splash10-004j-1963100000-5143703a60c7a96e3f24 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 10V, Positive-QTOF | splash10-00xr-0100900000-c1e9c84bd276f348e0e5 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 20V, Positive-QTOF | splash10-00dj-0270900000-06daa69e0687163420d1 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - hydroxyrepaglinide 40V, Positive-QTOF | splash10-01q9-2910100000-d3c133d353771a722c74 | 2021-09-22 | Wishart Lab | View Spectrum |
|
---|